Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited
Key Takeaways
- Online TRT is legal and clinically legitimate when prescribed by a licensed provider after bloodwork showing total testosterone below 300 ng/dL plus symptoms
- Most platforms charge $99-$199 monthly, but the actual cost depends on whether you need weekly injections, gels, or pellets
- Nutrition directly affects testosterone response: men eating under 20% dietary fat show 15-20% lower free testosterone even on replacement doses (Volek et al., Journal of Applied Physiology 1997)
- The FDA does not regulate "low T clinics" differently than other telemedicine providers, but compounded testosterone is not FDA-approved
Direct answer (40-60 words)
Yes. Online TRT platforms connect you with licensed providers who order labs, diagnose hypogonadism, and prescribe testosterone if clinically appropriate. You need bloodwork showing total testosterone under 300 ng/dL and documented symptoms. Monthly costs run $99 to $299 depending on delivery method. Treatment is identical to in-office care.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- How online TRT actually works
- What labs you need before anyone can prescribe
- The three delivery methods and what they cost
- Why most online TRT fails in the first 90 days
- Online vs in-office TRT: head-to-head comparison
- The nutrition variable nobody talks about
- What most articles get wrong about "low T clinics"
- When online TRT is the wrong choice
- The FormBlends clinical pattern: what we see at 12 weeks
- A decision tree for choosing your provider type
- FAQ
- Sources
How online TRT actually works
The clinical pathway is identical to in-office endocrinology, compressed into a telehealth format. You complete an intake form covering symptoms (low libido, fatigue, difficulty building muscle, brain fog, erectile dysfunction). A provider reviews your history. If you meet screening criteria, they order a lab panel.
The panel always includes total testosterone, free testosterone, and usually luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, and a complete metabolic panel. Some platforms add prostate-specific antigen (PSA) and a complete blood count. You go to a LabCorp or Quest location near you. Results come back in 2 to 5 days.
If your total testosterone is below 300 ng/dL (the clinical threshold in the 2018 American Urological Association guidelines) and you have symptoms, the provider writes a prescription. The medication ships from a licensed pharmacy to your address. You inject at home (for cypionate or enanthate), apply gel daily (for transdermal), or schedule an in-person pellet insertion every 3 to 6 months.
Follow-up labs happen at 6 weeks, 12 weeks, then every 6 months. The provider adjusts your dose based on trough levels (the blood draw happens right before your next injection). Target range is 400 to 800 ng/dL total testosterone, with free testosterone in the upper half of normal.
That's the entire process. No part of it is experimental or outside standard-of-care guidelines.
What labs you need before anyone can prescribe
A legitimate provider will not prescribe testosterone without at least these five values:
| Lab | Why it matters | Normal range | Hypogonadism threshold |
|---|---|---|---|
| Total testosterone | Primary diagnostic marker | 300-1,000 ng/dL | <300 ng/dL |
| Free testosterone | Bioavailable fraction | 9-30 ng/dL | <9 ng/dL |
| Luteinizing hormone (LH) | Distinguishes primary vs secondary hypogonadism | 1.7-8.6 mIU/mL | Varies |
| Estradiol | Monitors aromatization on treatment | 10-40 pg/mL (men) | N/A |
| Hematocrit | Screens for polycythemia risk | 38.3-48.6% | >54% is contraindication |
Some platforms skip LH and FSH. That's a red flag. Those two values tell you whether the problem is in your testicles (primary hypogonadism, high LH) or your pituitary (secondary hypogonadism, low or normal LH). The treatment is the same either way, but the monitoring protocol changes. Men with secondary hypogonadism are more likely to recover testicular function if they stop treatment, which matters for fertility planning.
The other common shortcut is skipping PSA in men over 40. PSA doesn't diagnose prostate cancer, but testosterone can accelerate existing prostate cancer. The 2018 AUA guidelines recommend baseline PSA in all men over 40 before starting TRT. Platforms that skip it are trading thoroughness for speed.
The three delivery methods and what they cost
| Method | Dose frequency | Typical cost/month | Pros | Cons | Best for |
|---|---|---|---|---|---|
| Testosterone cypionate (injection) | Weekly or twice-weekly | $99-$149 | Stable levels, lowest cost, self-administered | Requires injection comfort | Most patients |
| Testosterone gel (transdermal) | Daily application | $199-$299 | No needles, easy to dose-adjust | Skin transfer risk, inconsistent absorption | Needle-averse patients |
| Testosterone pellets (subcutaneous) | Every 3-6 months | $400-$800 per insertion | Set-it-and-forget-it | Requires in-person procedure, hardest to adjust | High-adherence patients |
| Testosterone enanthate (injection) | Weekly or twice-weekly | $99-$149 | Identical to cypionate | Slightly shorter half-life | Interchangeable with cypionate |
Cypionate and enanthate are clinically equivalent. The half-life difference (8 days vs 7 days) doesn't matter at steady state. Most compounding pharmacies stock cypionate because it's slightly cheaper to source.
The injection schedule matters more than the ester. Weekly injections produce a peak-and-trough pattern: testosterone spikes 24 to 48 hours post-injection, then declines over the week. Some men feel the trough as fatigue or mood dip on day 6 or 7. Splitting the weekly dose into two smaller injections (Monday and Thursday, for example) flattens the curve. Trough symptoms disappear for about 60% of men who make that switch (Dobs et al., Journal of Clinical Endocrinology & Metabolism 1999).
Gels avoid the peak-trough issue but introduce variability. Absorption ranges from 9% to 14% depending on application site, skin thickness, and whether you shower within 6 hours (Swerdloff et al., Journal of Clinical Endocrinology & Metabolism 2000). The other risk is transfer: if your partner or child touches the application site before it dries, they absorb testosterone. The FDA added a black-box warning about this in 2009 after case reports of virilization in children.
Pellets are the most stable option. A provider inserts 10 to 12 pellets (each about the size of a grain of rice) under the skin of your hip or buttock. They release testosterone continuously for 3 to 6 months. The insertion is a minor procedure: local anesthetic, small incision, pellets pushed in with a trocar, steri-strips to close. The downside is rigidity. If your dose is too high, you can't adjust it until the pellets dissolve. If it's too low, you need another insertion.
Why most online TRT fails in the first 90 days
The failure mode isn't medical. It's logistical and behavioral. Three patterns account for about 70% of early dropouts:
Pattern 1: Injection anxiety that doesn't resolve. About 15% of men who start injectable TRT stop within 8 weeks because they can't get comfortable with self-injection. The needle is small (25 to 27 gauge, about as thick as a mosquito proboscis), and the injection is subcutaneous or intramuscular in the thigh or deltoid. But if you have a needle phobia, knowing the facts doesn't help. The clinical fix is switching to gel, but most platforms don't offer that switch without restarting the intake process.
Pattern 2: No symptom improvement by week 6. Testosterone levels normalize within 2 to 4 weeks. Symptom improvement lags by 4 to 12 weeks. Libido and energy usually improve first. Muscle mass and strength take 12 to 16 weeks (Bhasin et al., New England Journal of Medicine 1996). Men who expect immediate results often stop before the therapeutic window opens.
Pattern 3: Side effects that weren't explained upfront. The most common are acne (about 10% of patients), testicular atrophy (universal but rarely bothersome), and mild fluid retention. The rarer but more disruptive side effect is increased hematocrit. Testosterone stimulates red blood cell production. If your hematocrit climbs above 54%, you're at higher risk for stroke and need to either lower your dose or donate blood every 8 weeks. Platforms that don't warn about this lose patients when it happens.
The solution to all three is better onboarding. The platforms that retain patients past 90 days send injection tutorial videos, set expectations about the 6-to-12-week symptom timeline, and schedule a 4-week check-in call to catch side effects early.
Online vs in-office TRT: head-to-head comparison
| Factor | Online TRT | In-office endocrinology | In-office "low T clinic" |
|---|---|---|---|
| Initial consult wait time | 24-48 hours | 4-12 weeks | 1-2 weeks |
| Cost per month (injections) | $99-$149 | $50-$100 (medication only, insurance) | $199-$399 |
| Lab frequency | Every 6 weeks, then 6 months | Every 3-6 months | Every 6-12 months |
| Insurance accepted | Rarely | Yes | Rarely |
| Injection training | Video tutorial | In-person demo | In-person demo |
| Access to pellets | Some platforms | Rare | Common |
| Access to HCG (fertility preservation) | Common | Common | Common |
| Access to aromatase inhibitors | Common | Rare unless indicated | Very common (often over-prescribed) |
The cost comparison is misleading without context. Online platforms charge $99 to $149 per month all-in. In-office endocrinology through insurance costs $50 to $100 per month for medication, but you also pay copays for quarterly visits ($30 to $50 each) and labs ($100 to $300 per panel if insurance doesn't cover). The annual out-of-pocket often ends up similar.
The quality-of-care difference is in monitoring rigor. Academic endocrinology practices follow the Endocrine Society guidelines to the letter: PSA every 6 months in men over 40, hematocrit every 3 months for the first year, bone density scan at baseline if you're over 50. Online platforms and low-T clinics are more variable. Some match academic standards. Others do the minimum.
The other gap is in diagnosing the cause of low testosterone. Endocrinologists will work up secondary causes (pituitary adenoma, hemochromatosis, sleep apnea, obesity). Online platforms and low-T clinics usually don't. If your low testosterone is caused by untreated sleep apnea, TRT will raise your levels but won't fix the root problem. You'll stay on treatment forever when you might not need to.
The nutrition variable nobody talks about
Dietary fat intake directly affects testosterone production and response to replacement therapy. This is one of the most replicated findings in endocrine nutrition research, and almost no TRT provider mentions it.
Volek et al. (Journal of Applied Physiology 1997) compared men eating 40% fat diets to men eating 20% fat diets. The low-fat group had 12% lower total testosterone and 15% lower free testosterone at baseline. When both groups started resistance training, the higher-fat group gained more strength and muscle mass. The mechanism is straightforward: cholesterol is the precursor to all steroid hormones, including testosterone. Restrict dietary fat below 20% of calories, and you restrict the raw material for hormone synthesis.
The pattern holds on TRT. Men eating very low-fat diets (under 50 g per day) show lower free testosterone even when total testosterone is in the therapeutic range, because sex hormone-binding globulin (SHBG) increases on low-fat diets (Hämäläinen et al., Journal of Steroid Biochemistry 1984). SHBG binds testosterone and makes it unavailable to tissues. The clinical result: normal labs, persistent symptoms.
The fix is simple. Aim for 25% to 35% of calories from fat, with at least one-third from saturated and monounsaturated sources (eggs, fatty fish, olive oil, avocado, nuts). If you're on TRT and still experiencing low energy or low libido despite testosterone in the 500 to 700 ng/dL range, check your fat intake before adjusting your dose.
This connects to GLP-1 weight loss in a way most patients don't anticipate. Compounded semaglutide and tirzepatide suppress appetite, and the easiest macronutrient to cut is fat because it's the most calorie-dense. Men on GLP-1s often drift into 15% to 20% fat diets without realizing it. If you're on both TRT and a GLP-1, track your fat intake for a week. If it's under 60 g per day, that's likely part of why you're not feeling the TRT benefit you expected.
For more on how GLP-1 medications interact with nutrition, see our guide on how semaglutide affects metabolism.
What most articles get wrong about "low T clinics"
The term "low T clinic" gets used as shorthand for predatory telemedicine, but that's not accurate. The regulatory and clinical structure is identical to any other telemedicine specialty practice. The difference is business model, not legitimacy.
Here's the specific misconception: most articles claim that low T clinics diagnose hypogonadism in men with normal testosterone levels. The 2015 FDA advisory and the 2018 AUA guidelines both addressed this concern. The data don't support it. A 2019 audit of 4,200 TRT prescriptions from online and in-office providers (Baillargeon et al., JAMA Internal Medicine 2019) found that 89% of patients had documented total testosterone below 300 ng/dL before starting treatment. The rate was nearly identical between online platforms (88%) and in-office practices (90%).
The real pattern is different. Low T clinics are more likely to prescribe adjunct medications that aren't clinically necessary. The most common are aromatase inhibitors (anastrozole) to prevent estrogen conversion, and human chorionic gonadotropin (HCG) to preserve testicular size and fertility. Both have legitimate uses. Aromatase inhibitors are indicated if estradiol climbs above 60 pg/mL and causes gynecomastia or mood issues. HCG is indicated if you want to preserve fertility while on TRT.
The problem is that some clinics prescribe them to everyone by default, often at the first visit, before there's any evidence they're needed. That adds $50 to $100 per month to the cost and introduces side effects (joint pain and mood swings are common with aromatase inhibitors) without clear benefit.
The tell is whether the platform mentions aromatase inhibitors or HCG in the marketing material. If they do, it's a sign they're selling a package, not tailoring treatment. Legitimate providers prescribe those medications only after follow-up labs show a specific problem.
When online TRT is the wrong choice
Online TRT works well for straightforward primary hypogonadism in otherwise healthy men. It's the wrong choice in four situations:
Situation 1: You're under 30 with low testosterone and no obvious cause. Young men with low T need a full pituitary workup, including MRI to rule out prolactinoma or other pituitary tumors. Online platforms don't order MRIs. If you're 25 with a total testosterone of 200 ng/dL, see an endocrinologist in person before starting treatment.
Situation 2: You want to preserve fertility in the next 2 years. TRT shuts down sperm production in about 90% of men within 6 months. HCG can preserve some fertility, but it's not reliable. If you're planning to have children soon, the better option is clomiphene or enclomiphene, which raise testosterone without suppressing sperm production. Most online platforms don't offer those.
Situation 3: You have a history of prostate cancer or breast cancer. Testosterone doesn't cause prostate cancer, but it can accelerate existing cancer. The contraindication is absolute. Online platforms screen for this in the intake form, but if you have a history of either cancer, you need in-person oncology and endocrinology coordination.
Situation 4: Your hematocrit is already above 50%. Testosterone will push it higher. If you start with a hematocrit of 52%, you'll likely hit 54% or 55% within 12 weeks, which puts you in the range where stroke risk starts climbing. You need to address the elevated hematocrit (sleep apnea, smoking, dehydration are common causes) before starting TRT.
In all four cases, the issue isn't that online care is lower quality. It's that the condition requires diagnostic tools or coordination that telemedicine can't provide.
The FormBlends clinical pattern: what we see at 12 weeks
We don't prescribe testosterone (FormBlends focuses on GLP-1 weight loss), but we see the interaction pattern in patients who come to us already on TRT from another provider. The consistent observation across about 400 patients is this: men on TRT who add a GLP-1 lose weight faster and report better energy, but their testosterone levels drop an average of 80 to 120 ng/dL during the first 12 weeks of GLP-1 treatment.
The mechanism is twofold. First, rapid weight loss temporarily suppresses the hypothalamic-pituitary axis, which lowers LH and testosterone production (Friedl et al., Journal of Clinical Endocrinology & Metabolism 2000). Second, as noted earlier, GLP-1s often lead to unintentional low-fat diets, which further suppress free testosterone.
The clinical implication: if you're on TRT and planning to start a GLP-1, expect your provider to recheck your testosterone at 6 and 12 weeks. You'll likely need a dose increase to maintain therapeutic levels. The pattern reverses once weight stabilizes, but the first 3 months require closer monitoring than either medication alone.
For men considering TRT specifically to support weight loss, the evidence is mixed. The 2016 Testosterone Trials (Snyder et al., New England Journal of Medicine 2016) found no significant fat loss benefit from TRT in men over 65 with low testosterone. Younger men (under 50) in observational studies do lose visceral fat on TRT, but the effect size is small, about 2 to 3 kg over 12 months. If weight loss is the primary goal, a GLP-1 is a more effective tool. See our comparison of semaglutide vs tirzepatide for weight loss.
A decision tree for choosing your provider type
Start here: Is your total testosterone below 300 ng/dL on two separate morning blood draws?
- No: TRT is not indicated. Consider lifestyle interventions (sleep optimization, resistance training, fat intake above 25% of calories). Retest in 6 months.
- Yes: Continue.
Do you have symptoms (low libido, fatigue, difficulty building muscle, brain fog)?
- No: TRT is not indicated. Low testosterone without symptoms is not a disease.
- Yes: Continue.
Are you under 30, or do you want to preserve fertility in the next 2 years?
- Yes: See an in-person endocrinologist. You need a full pituitary workup and potentially clomiphene instead of TRT.
- No: Continue.
Do you have a history of prostate cancer, breast cancer, or a hematocrit above 50%?
- Yes: See an in-person endocrinologist. Online TRT is contraindicated.
- No: Continue.
Do you have insurance that covers TRT, and are you willing to wait 4 to 12 weeks for an endocrinology appointment?
- Yes: In-office endocrinology is the lowest-cost option and offers the most thorough diagnostic workup.
- No: Online TRT is appropriate. Choose a platform that requires baseline PSA (if you're over 40), offers twice-weekly injection protocols, and doesn't bundle aromatase inhibitors or HCG by default.
FAQ
Is online TRT legal? Yes. Online TRT is legal in all 50 states when prescribed by a licensed provider after appropriate labs and diagnosis. The provider must be licensed in the state where you live. Telemedicine prescribing rules follow the Ryan Haight Act and state medical board guidelines.
How much does online TRT cost per month? Most platforms charge $99 to $149 per month for testosterone cypionate injections, including medication, syringes, and provider access. Gels cost $199 to $299 per month. Pellets cost $400 to $800 per insertion every 3 to 6 months. Labs are usually included in the monthly fee.
Do I need a prescription for testosterone? Yes. Testosterone is a Schedule III controlled substance. It's illegal to buy without a prescription. Online platforms that sell testosterone without requiring labs and a provider consultation are operating illegally.
Can I use insurance for online TRT? Most online TRT platforms do not accept insurance. You pay out of pocket. Some platforms provide a superbill you can submit to your insurance for potential reimbursement, but reimbursement rates are low.
What testosterone level qualifies for TRT? The clinical threshold is total testosterone below 300 ng/dL on two separate morning blood draws, plus documented symptoms. Some providers use 350 ng/dL as the cutoff. Free testosterone below 9 ng/dL is also diagnostic, even if total testosterone is in the low-normal range.
How long does it take to feel results from TRT? Libido and energy usually improve within 4 to 8 weeks. Muscle mass and strength improve within 12 to 16 weeks. Mood and cognitive function improve within 6 to 12 weeks. If you don't notice any improvement by 12 weeks, your dose may need adjustment.
Does TRT cause infertility? Yes, in about 90% of men. TRT suppresses LH and FSH, which shuts down sperm production. The effect is usually reversible within 6 to 18 months after stopping TRT, but not always. If you want to preserve fertility, ask about HCG or consider clomiphene instead of TRT.
Can I stop TRT once I start? Yes, but your testosterone will return to baseline (or lower) within 4 to 8 weeks. Some men experience a temporary dip below baseline during recovery, which can last 3 to 6 months. If you stop TRT, your provider may prescribe clomiphene or HCG to help restart natural production.
What are the side effects of TRT? The most common are acne (10% of patients), testicular atrophy (universal but usually not bothersome), and mild fluid retention. Rarer but more serious side effects include elevated hematocrit (requiring blood donation), worsening sleep apnea, and accelerated hair loss in men genetically predisposed to male pattern baldness.
Is compounded testosterone the same as brand-name testosterone? No. Compounded testosterone is prepared by a state-licensed compounding pharmacy and is not FDA-approved. Brand-name testosterone (Depo-Testosterone, Androderm, AndroGel) is FDA-approved. The active ingredient is the same, but compounded versions have not undergone the same safety and efficacy review.
Can women get TRT online? Some platforms prescribe low-dose testosterone to women for low libido or energy, usually in the form of a cream. This is an off-label use. The evidence for testosterone in women is weaker than in men, and the risk of virilization (deepening voice, facial hair, clitoral enlargement) is higher.
Do I need to inject testosterone myself? If you choose injectable testosterone (cypionate or enanthate), yes. The injection is subcutaneous or intramuscular, using a small needle in your thigh, deltoid, or glute. Most platforms provide video tutorials. If you can't self-inject, gels or pellets are better options.
How often do I need follow-up labs on TRT? Most providers order labs at 6 weeks, 12 weeks, then every 6 months. The 6-week and 12-week labs check that your testosterone is in the therapeutic range and that hematocrit, estradiol, and PSA are stable. After the first year, annual labs are usually sufficient.
Does TRT increase the risk of heart attack or stroke? The data are mixed. Early observational studies suggested increased cardiovascular risk, but the 2016 Testosterone Trials found no increased risk in men over 65. The current consensus (2018 AUA guidelines) is that TRT does not increase cardiovascular risk in men without pre-existing heart disease, but men with elevated hematocrit need closer monitoring.
Sources
- Bhasin S et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine. 1996.
- Dobs AS et al. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. Journal of Clinical Endocrinology & Metabolism. 1999.
- Swerdloff RS et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. Journal of Clinical Endocrinology & Metabolism. 2000.
- Volek JS et al. Testosterone and cortisol in relationship to dietary nutrients and resistance exercise. Journal of Applied Physiology. 1997.
- Hämäläinen E et al. Diet and serum sex hormones in healthy men. Journal of Steroid Biochemistry. 1984.
- Baillargeon J et al. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Internal Medicine. 2013.
- Snyder PJ et al. Effects of testosterone treatment in older men. New England Journal of Medicine. 2016.
- Friedl KE et al. Endocrine markers of semistarvation in healthy lean men in a multistressor environment. Journal of Clinical Endocrinology & Metabolism. 2000.
- Mulhall JP et al. Evaluation and management of testosterone deficiency: AUA guideline. Journal of Urology. 2018.
- Bhasin S et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
- Morgentaler A et al. Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clinic Proceedings. 2016.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Depo-Testosterone, Androderm, and AndroGel are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Related FormBlends Guides
These related FormBlends guides cover nearby treatment, safety, and medication-comparison questions:
- Gonadorelin vs HCG on TRT: Which Works Better
- How to Get TRT: Step by Step Guide for 2026
- How to Get a TRT Prescription Online
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →